These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer. Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700 [TBL] [Abstract][Full Text] [Related]
5. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
6. The activities of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer depend on where the sample is taken. Ogawa M; Ikeuchi K; Takao Y; Kobayashi T; Eto K; Ushigome T; Watanabe M; Anazawa S; Yamazaki Y; Yanaga K Oncol Rep; 2005 Aug; 14(2):331-5. PubMed ID: 16012711 [TBL] [Abstract][Full Text] [Related]
7. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y; Takahashi K; Saito T Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763 [TBL] [Abstract][Full Text] [Related]
8. [The thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio in pancreatic cancer]. Yu XJ; Jiang YJ; Fu DL; Ni QX Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):618-20. PubMed ID: 15634525 [TBL] [Abstract][Full Text] [Related]
9. Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer. Boskos CS; Liacos C; Korkolis D; Aygerinos K; Lamproglou I; Terpos E; Stoupa E; Baltatzis G; Beroukas K; Papasavvas P; Dimopoulos MA; Bamias A J Surg Oncol; 2010 Oct; 102(5):408-12. PubMed ID: 19877119 [TBL] [Abstract][Full Text] [Related]
10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739 [TBL] [Abstract][Full Text] [Related]
12. [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer]. Morimoto K; Koh M Gan To Kagaku Ryoho; 2004 Apr; 31(4):529-38. PubMed ID: 15114696 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in colorectal cancer and surrounding normal tissue. Zimovjanova M; Sykora V; Novotny J; Gatek J; Petruzelka L; Holubec L; Pecen L Neoplasma; 2005; 52(3):208-10. PubMed ID: 15875081 [TBL] [Abstract][Full Text] [Related]
14. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis]. Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505 [TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma. Oguri H; Maeda N; Yamamoto Y; Kusume T; Fukaya T Cancer Chemother Pharmacol; 2004 Feb; 53(2):151-4. PubMed ID: 14614573 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer. Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289 [TBL] [Abstract][Full Text] [Related]
17. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine. Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541 [TBL] [Abstract][Full Text] [Related]
18. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues. Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493 [TBL] [Abstract][Full Text] [Related]
19. The relationship between survival and the expression of dihydropyrimidine dehydrogenase in patients with colorectal cancer. Hotta T; Takifuji K; Taniguchi K; Sahara M; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H Oncol Rep; 2006 Jul; 16(1):177-82. PubMed ID: 16786143 [TBL] [Abstract][Full Text] [Related]
20. [Expression of mRNA levels of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in diffusely infiltrating colorectal cancer]. Ishibashi K; Sobajima J; Ohsawa T; Yokoyama M; Miyazaki T; Nakada H; Gonda T; Ishida H Gan To Kagaku Ryoho; 2007 Jul; 34(7):1073-7. PubMed ID: 17637543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]